DrShukry Zawahir

1. Six weeks of daily rifapentine vs. A comparator arm of 12-16 week rifamycin-based treatment of latent M. Tuberculosis infection: Assessment of safety, tolerability and effectiveness (ASTERoiD trial). A multinational Phase III clinical trial.

2. Assessing the impact of rifamycin-based tuberculosis preventative treatment on quality of life using mixed methods - A multinational sub-study within the ASTERoiD trial.

3. Phase II C clinical trial of novel, short-course regimens for the treatment of pulmonary tuberculosis: CRUSH-TB (Combination Regimens for Shortening TB Treatment).

4. Antimicrobial resistance and One-health intervention project in Vietnam.

5. Prescribing appropriateness criteria for older Sri Lankan adults.

6. Empowering Community Pharmacists in Advancing Tuberculosis Care Cascade: A Pilot Feasibility Study in Vietnam.

7. Evaluating effectiveness of multifaceted intervention on detection of leprosy among private healthcare providers: a quasi-experimental study in Indonesia.